Bayer buying?
Executive Summary
Aventis and Schering AG have entered into exclusive negotiations with Bayer to sell Aventis CropScience. Aventis holds a 76% interest and Schering owns 24%. Aventis would use the funds to pay down debt. Schering plans to put funds from the sale towards acquisitions or in-licensing arrangements
Aventis and Schering AG have entered into exclusive negotiations with Bayer to sell Aventis CropScience. Aventis holds a 76% interest and Schering owns 24%. Aventis would use the funds to pay down debt. Schering plans to put funds from the sale towards acquisitions or in-licensing arrangements. |